News
17h
MedPage Today on MSNNon-Hormonal Drug Reduced Hot Flashes From Endocrine Therapy for Breast CancerCHICAGO -- The neurokinin-targeted agent elinzanetant significantly reduced the frequency of hot flashes among women ...
Veozah (fezolinetant) was approved in 2023 by the FDA to treat moderate to severe hot flashes. A similar drug, elinzanetant, ...
Elinzanetant proved effective for managing disruptive vasomotor symptoms in women on endocrine therapy, supporting a Bayer ...
Certain symptoms of menopause get more attention than others. Most people are aware that hot flashes and night sweats can ...
5d
Flow Space on MSNCan This FDA-Approved Drug Tame Hot Flashes and Menopause Belly?When the FDA approved fezolinetant for treating moderate to severe hot flashes in menopausal women, the news made headlines.
How a Naturopath in St. Catharines Addresses the Root Causes” by Dr. Aoife Earls, ND, explores the deeper reasons behind ...
Several non-hormonal medications may help. “Gabapentin and Clonidine help minimize hot flashes by working with ... review and network meta-analysis of treatment effects from the National ...
The California legislature wants doctors to get more educated about menopause symptoms and treatment, part of a national ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results